These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8739684)

  • 21. Full panretinal photocoagulation and early vitrectomy improve prognosis of florid diabetic retinopathy.
    Favard C; Guyot-Argenton C; Assouline M; Marie-Lescure C; Pouliquen YJ
    Ophthalmology; 1996 Apr; 103(4):561-74. PubMed ID: 8618753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual dysfunction after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.
    Browning DJ
    Am J Ophthalmol; 2005 Jul; 140(1):127-8. PubMed ID: 16038654
    [No Abstract]   [Full Text] [Related]  

  • 23. Visual dysfunction after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.
    Salti H
    Am J Ophthalmol; 2006 Feb; 141(2):422; author reply 422-3. PubMed ID: 16458724
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe proliferative diabetic retinopathy treated with vitrectomy or panretinal photocoagulation: a monocenter randomized controlled clinical trial.
    Avitabile T; Bonfiglio V; Castiglione F; Castaing M; Contarino F; Mistretta A
    Can J Ophthalmol; 2011 Aug; 46(4):345-51. PubMed ID: 21816255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active prevention in diabetic eye disease. A 4-year follow-up.
    Kristinsson JK; Hauksdóttir H; Stefánsson E; Jónasson F; Gíslason I
    Acta Ophthalmol Scand; 1997 Jun; 75(3):249-54. PubMed ID: 9253967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ocular complications in diabetes: towards standardizing screening and care].
    Massin P
    Rev Prat; 2001 Oct; 51(16):1776-82. PubMed ID: 11795121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incidence of vision loss in a diabetic population.
    Moss SE; Klein R; Klein BE
    Ophthalmology; 1988 Oct; 95(10):1340-8. PubMed ID: 3265775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Henricsson M; Nilsson A; Janzon L; Groop L
    Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of post-treatment retinopathy after panretinal photocoagulation for proliferative diabetic retinopathy in type 1 diabetes.
    Bek T; Kjaergaard J
    Eur J Ophthalmol; 2004; 14(6):538-42. PubMed ID: 15638104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-reported visual function outcomes improve after ranibizumab treatment in patients with vision impairment due to diabetic macular edema: randomized clinical trial.
    Mitchell P; Bressler N; Tolley K; Gallagher M; Petrillo J; Ferreira A; Wood R; Bandello F;
    JAMA Ophthalmol; 2013 Oct; 131(10):1339-47. PubMed ID: 23974915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of state of the organ of sight in patients with diabetes type II].
    Wilczyński M; Dziegielewski K
    Klin Oczna; 2005; 107(10-12):672-4. PubMed ID: 16619817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Extracapsular cataract surgery with posterior chamber lens implantation in patients with diabetes mellitus - retrospective study on 145 patients].
    Kutschan A; Heinz P; Wiegand W
    Klin Monbl Augenheilkd; 2002 Mar; 219(3):117-24. PubMed ID: 11987038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optical coherence tomographic patterns in diabetic macular oedema: prediction of visual outcome after focal laser photocoagulation.
    Kim NR; Kim YJ; Chin HS; Moon YS
    Br J Ophthalmol; 2009 Jul; 93(7):901-5. PubMed ID: 19254904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening programme.
    Henricsson M; Tyrberg M; Heijl A; Janzon L
    Acta Ophthalmol Scand; 1996 Dec; 74(6):533-8. PubMed ID: 9017036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proliferative diabetic retinopathy in typical retinitis pigmentosa.
    Preethi S; Rajalakshmi AR
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 26021380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early detection of diabetic retinopathy.
    Harper CA; O'Day J; Taylor HR
    Med J Aust; 1995 May; 162(10):536-8. PubMed ID: 7776916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy.
    Mason JO; Yunker JJ; Vail R; McGwin G
    Retina; 2008 Oct; 28(9):1319-24. PubMed ID: 18667958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of laser photocoagulation treatment for diabetic macular oedema on patient's vision-related quality of life.
    Tranos PG; Topouzis F; Stangos NT; Dimitrakos S; Economidis P; Harris M; Coleman AL
    Curr Eye Res; 2004 Jul; 29(1):41-9. PubMed ID: 15370366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ophthalmic health care in diabetes mellitus: a cross-sectional study in northern Sweden.
    Reuterving CO; Kratholm J; Wachtmeister L
    Ophthalmic Epidemiol; 1999 Dec; 6(4):267-78. PubMed ID: 10544341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The National Diabetic Retinopathy Laser Treatment Audit. III. Clinical outcomes.
    Bailey CC; Sparrow JM; Grey RH; Cheng H
    Eye (Lond); 1999 Apr; 13 ( Pt 2)():151-9. PubMed ID: 10450373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.